Immunogenicity and safety of the new reduced-dose tetanus–diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study

A new reduced-dose tetanus–diphtheria (Td) vaccine was developed in Korea, and phase I and II clinical trials were successfully undertaken. We conducted this double-blind, randomized, multicenter phase III clinical trial to assess the immunogenicity and safety of the new Td vaccine. Methods: Healthy...

Full description

Bibliographic Details
Main Authors: Seung Beom Han, Jung-Woo Rhim, Hye Jo Shin, Sang Yong Kim, Jong-Hyun Kim, Hyun-Hee Kim, Kyung-Yil Lee, Hwang Min Kim, Young Youn Choi, Sang Hyuk Ma, Chun Soo Kim, Dong Ho Kim, Dong Ho Ahn, Jin Han Kang
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118215007549

Similar Items